Facilitating Functional Independence in Patients Receiving Prolonged Mechanical Ventilation

NCT ID: NCT02847988

Last Updated: 2021-03-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-07-31

Study Completion Date

2022-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary aim of this proposal is to test the effectiveness of neuromuscular electrical stimulation (NMES) in improving functional status and muscle function in patients receiving prolonged mechanical ventilation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Muscle Weakness

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Neuro-muscular electrical stimulation

Intervention:Neuromuscular electrical stimulation (NMES)

NMES stimulation will be applied to lower extremity muscle groups up to 5 days a week until discharge. Standard physical therapy will also be administered by a therapist distinct from the therapist administering NMES

Group Type ACTIVE_COMPARATOR

Neuromuscular electrical Stimulation (NMES)

Intervention Type DEVICE

Electrical stimulation of lower extremities will be applied using an electrotherapy stimulator device (Vectra® Neo). The intensity of stimulation will be titrated based on maximal tolerable muscle contraction

Sham stimulation

Intervention: sham stimulation

Sham stimulation will be applied to lower extremity muscle groups up to 5 days a week until discharge. Standard physical therapy will also be administered by a therapist distinct from the therapist administering sham-NMES

Group Type SHAM_COMPARATOR

Sham Stimulation

Intervention Type DEVICE

Sham stimulation of lower extremities will be applied using an electrotherapy stimulator device (Vectra® Neo).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Neuromuscular electrical Stimulation (NMES)

Electrical stimulation of lower extremities will be applied using an electrotherapy stimulator device (Vectra® Neo). The intensity of stimulation will be titrated based on maximal tolerable muscle contraction

Intervention Type DEVICE

Sham Stimulation

Sham stimulation of lower extremities will be applied using an electrotherapy stimulator device (Vectra® Neo).

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Duration of mechanical ventilation \>14 days
* Sufficiently awake
* Able to speak and comprehend English
* Willingness to participate

Exclusion Criteria

* Cardiopulmonary Instability
* Acute-onset neuromuscular disease
* Lower-extremity amputee or paresis
* Open wound at electrode application points
* Pitting edema grade ≥3
* Presence of pacemaker, implanted defibrillator, or ventricular-assist device
* inability to transfer from sitting to standing before critical illness
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute of Nursing Research (NINR)

NIH

Sponsor Role collaborator

RML Specialty Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Amal Jubran

Principal Investigator-Staff Physician

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Amal Jubran, MD

Role: PRINCIPAL_INVESTIGATOR

RML Specialty Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

RML Specialty Hospital

Hinsdale, Illinois, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Lisa A Duffner, B.A.,B.S.

Role: CONTACT

630-286-4149

Amal Jubran, MD

Role: CONTACT

708-202-2705

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Lisa Duffner

Role: primary

630-286-4149

Maryann Oliver

Role: backup

630-286-4127

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R01NR016055

Identifier Type: NIH

Identifier Source: secondary_id

View Link

AXJ014

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.